Onyx Sues Partner Bayer Over New Cancer Treatment

Law360, New York (May 18, 2009, 12:00 AM EDT) -- Onyx Pharmaceuticals Inc. has sued Bayer AG, accusing its longtime partner of surreptitiously developing a successor treatment to their joint cancer drug Nexavar.

In the lawsuit filed Friday in the U.S. District Court for the Northern District of California, Onyx asserted its rights to a Phase 2 anti-cancer compound that it says was discovered during joint research between it and Bayer.

"Onyx and Bayer have had a long-standing and successful collaboration for more than 15 years,” said Greg Giotta, vice president and chief legal counsel of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.